geroFarma

geroFarma has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €240,699 and a net result of €107,225. Equity is growing by ~66.7% per year across the filed fiscal years. Its solvency ranks better than 34% of 12386 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).